Exelixis
EXEL
#1760
Rank
A$16.95 B
Marketcap
A$62.99
Share price
-0.71%
Change (1 day)
15.29%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company